3-(4-fluorophenyl)-7-[4-(4-methylpiperazin-1-yl)phenyl]imidazo[1,2-a]pyridine;3-(3-methyl-4-pyridinyl)-7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridine;5-[7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridin-3-yl]-1,3-thiazole;7-(4-propan-2-yloxyphenyl)-3-thiophen-2-ylimidazo[1,2-a]pyridine;7-(4-propan-2-yloxyphenyl)-3-thiophen-3-ylimidazo[1,2-a]pyridine
C105H97FN14O4S3 — CID 158132931
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-fluorophenyl)-7-[4-(4-methylpiperazin-1-yl)phenyl]imidazo[1,2-a]pyridine;3-(3-methyl-4-pyridinyl)-7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridine;5-[7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridin-3-yl]-1,3-thiazole;7-(4-propan-2-yloxyphenyl)-3-thiophen-2-ylimidazo[1,2-a]pyridine;7-(4-propan-2-yloxyphenyl)-3-thiophen-3-ylimidazo[1,2-a]pyridine
3-(4-fluorophenyl)-7-[4-(4-methylpiperazin-1-yl)phenyl]imidazo[1,2-a]pyridine;3-(3-methyl-4-pyridinyl)-7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridine;5-[7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridin-3-yl]-1,3-thiazole;7-(4-propan-2-yloxyphenyl)-3-thiophen-2-ylimidazo[1,2-a]pyridine;7-(4-propan-2-yloxyphenyl)-3-thiophen-3-ylimidazo[1,2-a]pyridine (PubChem CID 158132931) has the molecular formula C105H97FN14O4S3 and a molecular weight of 1734.22 g/mol. Its IUPAC name is 3-(4-fluorophenyl)-7-[4-(4-methylpiperazin-1-yl)phenyl]imidazo[1,2-a]pyridine;3-(3-methyl-4-pyridinyl)-7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridine;5-[7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridin-3-yl]-1,3-thiazole;7-(4-propan-2-yloxyphenyl)-3-thiophen-2-ylimidazo[1,2-a]pyridine;7-(4-propan-2-yloxyphenyl)-3-thiophen-3-ylimidazo[1,2-a]pyridine.
Molecular Properties
| Compound Name | 3-(4-fluorophenyl)-7-[4-(4-methylpiperazin-1-yl)phenyl]imidazo[1,2-a]pyridine;3-(3-methyl-4-pyridinyl)-7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridine;5-[7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridin-3-yl]-1,3-thiazole;7-(4-propan-2-yloxyphenyl)-3-thiophen-2-ylimidazo[1,2-a]pyridine;7-(4-propan-2-yloxyphenyl)-3-thiophen-3-ylimidazo[1,2-a]pyridine |
|---|---|
| PubChem CID | 158132931 |
| Molecular Formula | C105H97FN14O4S3 |
| Molecular Weight | 1734.22 g/mol |
| Exact Mass | 1732.70 |
| IUPAC Name | 3-(4-fluorophenyl)-7-[4-(4-methylpiperazin-1-yl)phenyl]imidazo[1,2-a]pyridine;3-(3-methyl-4-pyridinyl)-7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridine;5-[7-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridin-3-yl]-1,3-thiazole;7-(4-propan-2-yloxyphenyl)-3-thiophen-2-ylimidazo[1,2-a]pyridine;7-(4-propan-2-yloxyphenyl)-3-thiophen-3-ylimidazo[1,2-a]pyridine |
| SMILES | CC(C)Oc1ccc(-c2ccn3c(-c4cccs4)cnc3c2)cc1.CC(C)Oc1ccc(-c2ccn3c(-c4ccsc4)cnc3c2)cc1.CC(C)Oc1ccc(-c2ccn3c(-c4cncs4)cnc3c2)cc1.CN1CCN(c2ccc(-c3ccn4c(-c5ccc(F)cc5)cnc4c3)cc2)CC1.Cc1cnccc1-c1cnc2cc(-c3ccc(OC(C)C)cc3)ccn12 |
| InChI | InChI=1S/C24H23FN4.C22H21N3O.2C20H18N2OS.C19H17N3OS/c1-27-12-14-28(15-13-27)22-8-4-18(5-9-22)20-10-11-29-23(17-26-24(29)16-20)19-2-6-21(25)7-3-19;1-15(2)26-19-6-4-17(5-7-19)18-9-11-25-21(14-24-22(25)12-18)20-8-10-23-13-16(20)3;1-14(2)23-18-5-3-15(4-6-18)16-7-9-22-19(12-21-20(22)11-16)17-8-10-24-13-17;1-14(2)23-17-7-5-15(6-8-17)16-9-10-22-18(13-21-20(22)12-16)19-4-3-11-24-19;1-13(2)23-16-5-3-14(4-6-16)15-7-8-22-17(10-21-19(22)9-15)18-11-20-12-24-18/h2-11,16-17H,12-15H2,1H3;4-15H,1-3H3;2*3-14H,1-2H3;3-13H,1-2H3 |
| InChIKey | FSZQNFXSWZWUON-UHFFFAOYSA-N |
| XLogP | 25.66 |
| TPSA | 155.68 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 127 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1734.22 |
| LogP ≤ 5 | 25.66 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 21 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158132931 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.